Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen and NBUVB in Vitiligo Non-Photoadapters
NCT05256147Terminated
- Sponsor
- Henry Ford Health
- Start
- Aug 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ibuprofen in Vitiligo, sponsored by Henry Ford Health. Primary endpoint: Vitiligo Area Scoring Index at 4 months. Started Aug 2015; status: terminated.
02
Drugs
ibuprofen
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT05256147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05256147.